Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 for schizophrenia.
In GlendaleThis study is completed in China. It focuses on Depression.
In ShanghaiThis study was terminated in the United States. It is testing clinical Utility of Antipsychotic Medication Levels for Schizophrenia.
Multiple locations, including TorranceThis study is completed in the United States. It is testing buprenorphine/Naloxone for Addiction.
In Overland ParkThis study is completed in the United States. It is testing Effect of AZD4041 on Respiratory Drive for Addiction.
In Overland ParkThis study was terminated in the United States. It is testing Effects Of PF-04457845 On BOLD fMRI for PTSD.
In New YorkThis study was terminated in the United States, in Japan, in Spain, .... It is testing Effects of RO6889450 (Ralmitaront) for schizophrenia.
Multiple locations, including BellflowerThis study is completed in China. It is testing KarXT for schizophrenia.
Multiple locations, including HefeiThis study is completed in the United States. It is testing ML-007C-MA for schizophrenia.
Multiple locations, including Little RockThis study was terminated in the United States. It is testing REL-1017 for depression.
Multiple locations, including HomewoodThis study is completed in the United States. It is testing solriamfetol for ADHD.
Multiple locations, including EncinoThis study is completed in the United States. It is testing Efficacy, Safety, and Tolerability of Oral NORA520 for depression.
Multiple locations, including BentonvilleHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.